JOLT — Jolt Health Income Statement
0.000.00%
- CA$0.64m
- CA$0.64m
Annual income statement for Jolt Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.33 | 0.128 | 9.52 | 3.61 | 0.775 |
Operating Profit | -0.33 | -0.128 | -9.52 | -3.61 | -0.775 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.121 | -0.325 | -9.52 | -3.58 | -0.766 |
Net Income After Taxes | -0.121 | -0.325 | -9.52 | -3.58 | -0.766 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.121 | -0.325 | -9.52 | -3.58 | -0.766 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.121 | -0.325 | -9.52 | -3.58 | -0.766 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.018 | -0.036 | -0.386 | -0.039 | -0.006 |
Dividends per Share |